Navigation Links
Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform

Fourteen Novalis Tx(TM) Orders Since September Launch Reinforce Strength of


PALO ALTO, Calif. and MUNICH, Germany, Jan. 24 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) and BrainLAB AG are today announcing that they have booked fourteen orders for the new Novalis Tx(TM) radiosurgical platform, which combines the most successful technologies from both companies to offer superior noninvasive treatment options for patients. The orders for the Novalis Tx platform, which was launched in September 2007, include 10 in the United States and four in Europe.

"Novalis Tx orders have come in at twice the rate normally seen for any type of radiosurgical device and we are delighted with the early response from the surgical community," says Dow Wilson, President of Varian's Oncology Systems business. "We have received orders from some of the world's leading surgical and radiotherapy centers as well as from community hospitals that are intent on enhancing their radiosurgical capabilities."

Jean Hooks, General Manager Oncology Solutions at BrainLAB, adds, "The imaging capabilities Novalis Tx offers are unmatched in the industry and are representative of the power our partnership brings to the field of radiosurgery. Novalis Tx answers strong demand from the clinical community for a fast, versatile, ultra-precise radiosurgery device that advances current standards of care."

Novalis Tx offers a wide range of treatment options for a large number of indications, including malignant and benign lesions, brain metastases, arteriovascular malformations, and functional lesions. It features the highest dose delivery rates in the industry, dynamic ultra-fine beam shaping, and frameless patient positioning for more rapid, effective, and comfortable treatments.

"Novalis Tx has the dose delivery rate, advanced imaging, and high definition beam shaping capability needed to offer faster, more precise, more comfortable radiosurgical procedures for our patients," said Fang-Fang Yin, Ph. D., professor and director of radiation physics at Duke University School of Medicine, which is completing the installation of a Novalis Tx.

Unlike other radiosurgical devices, Novalis Tx allows multiple beam energies from 6 to 20 million electron volts for treating deep-seated tumors and sparing surrounding healthy tissue more effectively. Clinics can treat twice the number of patients per day than with any other stereotactic radiosurgery system on the market. "The speed coupled with the precise beam shaping and advanced imaging capabilities make the most advanced radiosurgical treatments more affordable for hospitals and their patients," adds Dow Wilson.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing

comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit

About BrainLAB

BrainLAB develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and also less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. This utility has been further expanded to serve as a computer terminal for physicians to more effectively access and interpret diagnostic scans and other digital medical information for better informed decisions. BrainLAB solutions allow expansion from a single system to operating suites to digitally integrated hospitals covering all subspecialties from neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology. With more than 2,950 systems installed in over 70 countries, BrainLAB is a market leader in image-guided technology. The privately held BrainLAB group, founded in 1989, is headquartered in Munich, Germany and today employs more than 950 people in 16 offices across Europe, Asia, Australia, North and South America.
For more information, visit BrainLAB at


Spencer Sias, (650) 424-5782

Kate Franco, (708) 486-1915

SOURCE Varian Medical Systems, Inc.; BrainLAB AG
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
(Date:6/26/2016)... , ... June 27, 2016 , ... Quality metrics are ... in many ways they remain in the eye of the beholder, according to experts ... publication of The American Journal of Managed Care. For the full issue, click ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: ) , ... , TwinLink™ - the first dual communication ...
Breaking Medicine Technology: